Macrophage activation syndrome at the onset of glucocorticoid-resistant systemic lupus erythematosus: a case report
Introduction. Macrophage activation syndrome (MAS) is a life-threatening hyperinflammatory state mediated by uncontrolled cytokine storm and haemophagocytosis. Although rarely reported, MAS might occur in systemic lupus erythematosus (SLE), notably as an inaugural manifestation. Glucocorticoids (GCs...
Main Authors: | Tulbă Delia, Balea Marius, Băicuş Cristian |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2018-03-01
|
Series: | Romanian Journal of Internal Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1515/rjim-2017-0035 |
Similar Items
-
Macrophage Activation Syndrome as a Complication of Systemic Lupus Erythematosus in an Adult Male
by: Rajesh Gopalarathinam, et al.
Published: (2020-04-01) -
GLUCOCORTICOIDS IN THE THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS
by: T. M. Reshetnyak, et al.
Published: (2014-07-01) -
GLUCOCORTICOIDS IN THE THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS
by: T. M. Reshetnyak, et al.
Published: (2014-07-01) -
Glucocorticoid‐induced osteonecrosis in systemic lupus erythematosus patients
by: Kaichi Kaneko, et al.
Published: (2021-10-01) -
GLUCOCORTICOIDS IN THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS: POSITIVE AND NEGATIVE ASPECTS
by: N. V. Seredavkina, et al.
Published: (2014-11-01)